1.
2.
Urology
; 160: 19-21, 2022 02.
Article
in English
| MEDLINE
| ID: mdl-34752847
3.
Urol Case Rep
; 33: 101350, 2020 Nov.
Article
in English
| MEDLINE
| ID: mdl-33102050
ABSTRACT
We present a case of a 69 year old man with phimosis associated with immunotherapy with durvalumab for metastatic non-small-cell lung cancer. The patient developed vitiligo like dermatosis after the induction dose of durvalumab, subsequent administration of the immunotherapy the patient developed a fibrous ring of the foreskin. Immune-mediated adverse reactions have been described after the use of durvalumab, but, to our knowledge, there are no reports of phimosis and vitiligo like reactions.